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Thrombocytopenia is included in the classification criteria for systemic lupus erythematosus (SLE). However,
severe thrombocytopenia causing spontaneous bleeding is rare. Here, we describe a 22-year-old woman who
presented with spontaneous hemoperitoneum as the first manifestation of SLE. Laboratory findings compatible
with SLE included positive antinuclear antibody and a false-positive venereal disease research laboratory.
Symptoms suggesting the disease were not prominent early after admission, but headache and seizures that
developed on the 3rd day of admission led to the diagnosis of SLE. The brain magnetic resonance imaging and
angiography findings were compatible with the neuropsychiatric manifestations of SLE. High-dose steroid and
monthly intravenous cyclophosphamide pulse therapy were effective at improving the headache and seizure, as
well as the hemoperitoneum. (Korean J Intern Med 2010;25:458-460)
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INTRODUCTION
Systemic lupus erythematosus (SLE) is an autoimmune
disease with diverse clinical manifestations [1]. Mild
symptoms, such as arthritis and skin rash, predominate in
frequency, but life-threatening manifestations requiring
aggressive immunosuppressive therapy can also develop.
Thrombocytopenia may precede the other manifesta-
tions of SLE [2], but severe thrombocytopenia accomp-
anying spontaneous bleeding is rare. As other diseases can
cause thrombocytopenia, thrombocytopenia alone in the
absence of other symptoms of SLE may cause the
physician to delay in starting aggressive therapy.
Here, we report the case of a 22-year-old woman who
suffered from spontaneous hemoperitoneum as the initial
manifestation of SLE.
CASE REPORT
A 22-year-old woman suffering from vaginal bleeding
was referred to our hospital from a local clinic. After
admission in the gynecology department, she complained
of diffuse abdominal pain, fatigue, and weakness. The
vaginal bleeding had continued for more than 10 days
after her last menstruation. The patient’s body
temperature, blood pressure, pulse rate, and respiratory
rate were 36.9°C, 140/80 mm/Hg, 88/minute, and
22/minute, respectively. Her conjunctivae looked pale.
Petechiae were found on the entire body, but there was no
specific tender point on her abdomen.
The complete blood count showed a white blood cell
count of 8,960/µL (85.5% neutrophils, 11.9% lymphocytes,
1.5% monocytes), hemoglobin 6.7 g/dL, hematocrit
22.4%, and platelet count 7,000/µL. The values of
coagulation tests were within normal limits. Since the
pelvic ultrasound suggested a large amount of fluid,
computed tomography (CT) of the abdomen and pelvis
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was performed, and demonstrated a large amount of
blood with a 4.5 × 4 cm ill-defined mass-like lesion in the
right adnexa suggesting a ruptured hemorrhagic corpus
luteal cyst (Fig. 1). Given the severe thrombocytopenia,
emergency surgery was delayed and a blood transfusion
was started. Evaluating the possible causes of
thrombocytopenia, the gynecologists consulted us for
rheumatologic causes. We considered SLE and idiopathic
thrombocytopenic purpura (ITP) as possible causes of
thrombocytopenia.
Additional laboratory findings were as follows:
increased antinuclear antibody titer (over 1:320, speckled
pattern); false-positive venereal disease research
laboratory (VDRL; FTA-ABS and TPHA tests were
negative); decreased complement fractions (complement
3: 69 mg/dL [normal, 90 to 180], complement 4: 10
mg/dL [normal, 10 to 40]); positive platelet associated
immunoglobulin G (IgG) antibody. The anti-dsDNA
antibody, anti-Smith antibody, antibodies targeting
extractable nuclear antigens, anticardiolipin antibody
(IgG and IgM), and lupus anticoagulant were negative.
Serologic tests for Epstein-Barr virus, cytomegalovirus,
and human immunodeficiency virus (HIV) were all
negative. A bone marrow biopsy revealed increased
megakaryocytes, suggesting peripheral destruction or
sequestration. Findings compatible with SLE were clear,
but were insufficient to conclude that SLE was the cause of
the thrombocytopenia; ITP seemed to be a more likely
cause.
On the 3rd day of admission, she suffered from a severe
headache and generalized seizure lasting for 1 minute. We
performed brain magnetic resonance imaging (MRI),
which showed multifocal cortical and subcortical
hyperintensities in both cerebral and cerebellar
hemispheres (Fig. 2). Angiography revealed multifocal
stenosis and post-stenotic dilatation of the cerebral
arteries compatible with vasculitis (Fig. 3). Those findings
led us to conclude that the patient had SLE and she was
transferred to our rheumatology department.
Since the patient's thrombocytopenia was severe, we
administered intravenous (IV) immunoglobulin first, and
then started intravenous steroid pulse therapy (1 g/day)
for 3 consecutive days. After the therapy, we recommend-
ed monthly cyclophosphamide (CYC) pulse therapy (750
mg/m
2) because of her life-threatening manifestat-ions:
severe thrombocytopenia and cerebral vasculitis.
The petechiae disappeared and the platelet count
increased to 229,000/µL after the therapy. The
Figure 1. Pelvic CT shows a large amount of hemoperitoneum
(small arrows) and a 4.5 × 4-cm ill-defined mass-like lesion
with irregular enhancement in the right adnexa (large arrow).
Figure 2. Brain MRI shows multiple hyperintense lesions in
both cerebellar hemispheres.
Figure 3. Angiography shows multifocal stenoses and post-
stenotic dilatations of the cerebral vessels.
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complement 3 and 4 levels were increased to 97 and 15
mg/dL, respectively. Pelvic ultrasound performed after
the therapy showed only a scant amount of fluid.
As the improvements in her symptoms and laboratory
findings were marked, we discharged the patient and
recommended she take prednisolone at a dose of 1 mg/kg.
After discharge, she underwent monthly CYC pulse
therapy twice without severe adverse events.
DISCUSSION
Thrombocytopenia lower than 100,000/µL during the
course of SLE is found in about 20% of cases [3], but
severe thrombocytopenia causing spontaneous bleeding is
rare. In this case, there was severe thrombocytopenia, but
other symptoms suggesting SLE were not prominent
initially. Although laboratory findings, including a false-
positive VDRL and high antinuclear antibody titer,
supported the diagnosis of SLE, they were insufficient to
declare that the patient had SLE. Alternatively, the
positive platelet-associated IgG antibody and bone
marrow findings suggested the diagnosis of ITP. However,
the development of a seizure and the MRI and
angiographic findings confirmed the diagnosis of SLE.
Approximately 3 to 16% of patients with ITP not
meeting the American College of Rheumatology criteria
for SLE ultimately evolve into SLE [4], emphasizing the
need for further monitoring of patients who seem to have
ITP.
The neuropsychiatric syndromes of SLE (NPSLE)
include 19 manifestations [5], including psychosis and
seizures, as classification criteria [6]. Although severe
neurological manifestations of SLE mandate immediate
therapy, only one randomized controlled trial of the
effectiveness of intravenous CYC for NPSLE has been
conducted [7]. At present, even without evidence, CYC
seems to be the most effective drug for severe,
inflammatory neuropsychiatric lupus [7]. Based on
studies of the effectiveness of CYC for severe
thrombocytopenia and NPSLE [7,8], we treated the
patient with IV CYC with high-dose steroid and she
improved.
Many cases with a ruptured corpus luteum and
hemoperitoneum are reported in the general population
[9], but only one case of spontaneous ovarian rupture with
hemoperitoneum has been reported in an SLE patient
[10]. We experienced a patient with SLE, presenting with
spontaneous hemoperitoneum due to severe thromb-
ocytopenia as the first manifestation.
In conclusion, severe thrombocytopenia accompanying
spontaneous bleeding can be the initial manifestation of
SLE. An effort to discover symptoms, signs, and
laboratory findings associated with the disease should be
made so appropriate therapy is not delayed.
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